77.4 F
New York
Thursday, July 29, 2021

Gilead Sciences [NASDAQ: GILD] Announces Agreement With Jounce [NASDAQ: JNCE]

Must read

Digital Realty [NYSE: DLR] Considering Developing 64 MW Facility in South Korea

Digital Realty Trust, Inc. has shown its intention to build the 64-megawatt facility in Seoul, South Korea. The firm has decided that the...

Why Shares of IZEA Worldwide [NASDAQ: IZEA] Skyrocketing Today?

Shares of IZEA Worldwide, Inc. surged 8.10% at the time of writing on Wednesday. The strong performance of the firm has highlighted the...

BIT Mining [NYSE: BTCM] Ink Purchase Agreement to Buy Bitcoin Mining Machine

BIT Mining Limited has inked a purchase agreement to increase the fleet of bitcoin mining machines. As per the new purchase agreement, the...

Dyadic International [NASDAQ: DYAI] Inks Licensing Agreement with the Rubic Consortium

Dyadic International, Inc. disclosed that it has inked a COVID-19 vaccine technology transfer and licensing agreement with the Rubic Consortium. It has been...

Gilead Sciences, Inc. [NASDAQ: GILD] announced Tuesday it has signed a new deal with Jounce Therapeutics, Inc. [NASDAQ: JNCE] for a novel Immunotherapy program. The purpose of the deal is to license the JTX-1811 program.

Gilead Sciences will have exclusive rights to develop and commercialize Anti-CCR8 antibodies. JTX-1811 is a monoclonal antibody developed to selectively destroy immunosuppressive tumor-infiltrating T regulatory (TITR) cells.

Shares of Gilead Sciences traded down 1.00% after losing -0.67 on Tuesday. It has a day low range of 66.06 and a day high range of 66.47.

Gilead Sciences Inc last closed at $66.08, in a 52-week range of $60.89 to $85.97. It has traded up 8.52% from its 52-weeks low and traded down -23.14% from its 52-weeks high.

Let’s take a quick look at its profitability, it has a return on assets (ROA) of -0.40%, return on equity (ROE) of -1.20%, and return on investment (ROI) of 9.50%.

Furthermore, Gilead Sciences has a Gross Margin of 78.60%, a Profit Margin of -1.20%, and an Operating Margin of -4.30%.

Gilead Sciences (GILD) has a current ratio of 2.30. Moreover, its quick ratio is 2.20. The market cap of GILD has remained high, hitting $84.06 billion at the time of writing.

Now looking at the share price of Jounce Therapeutics soared 70.04%, as it gained +3.39 on Tuesday. It has a day low and high range of $7.10 and $8.50, respectively.

The share price of Jounce Therapeutics went from a low point around $2.79 to briefly over $10.00 in the past 52 weeks, though shares have since pulled back to $8.23. JNCE market cap has remained high, hitting $157.59 million at the time of writing.

Turing our focus on its profitability, its return on assets (ROA), return on equity (ROE), and return on investment (ROI) is 11.30%, 13.50%, and 30.20%. Furthermore, its Profit Margin is 18.20%.

If we look at the terms of the Agreement, will pays an upfront payment of $85 million to, and a $35 million equity investment at a premium in, Jounce upon closing.

Additionally, Jounce may get up to an additional $685 million in future clinical, regulatory, and commercial milestone payments.

Jounce will lead the development of JTX-1811 through IND clearance, after that Gilead Sciences will have exclusive rights to develop JTX-1811. The deal is expected to close in the second half of 2020.

More articles

Latest article

Binance, FTX Cut Leverage Limits on Crypto Futures Trading to 20x

Two major cryptocurrency trading platforms Binance Futures and FTX disclosed on Monday that they both have made a remarkable decision related to the crypto...

TD Holdings [NASDAQ: GLG] Inks Letter of Intent with Guangdong Jinbochuang

TD Holdings, Inc. has inked a letter of intent (LOI) with Guangdong Jinbochuang Special Purpose Vehicle Co., Ltd. and (Jinbochuang) and Hunan Jinmeike...

ASGN [NYSE: ASGN] Acquire IndraSoft Inc

ASGN Incorporated disclosed that it has acquired IndraSoft Inc. IndraSoft Inc has gained recognition as a prominent cybersecurity and digital transformation solutions offeror...

Link Reservations Decides to Accept Bitcoin/Crypto Payments

Link Reservations Inc disclosed Friday that it has decided to start accepting Bitcoin and cryptocurrency payments. This is the major breakthrough for the firm...

Athene [NYSE: ATH] Announces Acquisition of Foundation Home Loans

Athene Holding Ltd. disclosed on Thursday that it has inked a definitive agreement to purchase Foundation Home Loans (FHL). FHL had a £3...

Ping [NYSE: PING] and Anexinet Announces Partnership

Ping Identity Holding Corp. and Anexinet Corporation have both entered into a partnership agreement. The collaboration will integrate Ping Identity’s centralized Identity Access...

Digital Realty [NYSE: DLR] and Brookfield Announces Joint Venture

Digital Realty Trust, Inc.   and Brookfield Infrastructure Partners L.P. and its institutional partners disclosed on Wednesday that they have launched a 50/50 joint...

Red Cat [NASDAQ: RCAT] Announces Acquisition of Teal Drones

Red Cat Holdings, Inc. has inked an agreement on Tuesday to buy Teal Drones in an all-stock transaction. This acquisition will add Teal...